Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Secretomes in Severe COVID-19
NCT05122234Phase 3Completed
- Sponsor
- Universitas Indonesia
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Lipid-based Nanoparticles, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of mesenchymal stem cell secretome in coronavirus disease 2019 (COVID-19), sponsored by Universitas Indonesia. Started Aug 2020; status: completed.
02
Drugs
mesenchymal stem cell secretome
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05122234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05122234.